Increase/Decrease in Cash: The total change in cash for the company over the given period.
Greenwich LifeSciences, Inc. (GLSI) had Increase/Decrease in Cash of $-0.28M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.15M |
|
-- |
|
-- |
|
$4.17M |
|
$-4.17M |
|
$0.02M |
|
$-4.15M |
|
$-4.15M |
|
$-4.15M |
|
$-4.15M |
|
$-4.15M |
|
$-4.15M |
|
$-4.17M |
|
$-4.17M |
|
13.64M |
|
13.64M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$3.81M |
|
-- |
|
-- |
|
$3.81M |
|
$1.62M |
|
-- |
|
-- |
|
$1.62M |
|
$2.19M |
|
$2.19M |
|
$2.19M |
|
13.79M |
|
| Cash Flow Statement Financials | |
$-6.74M |
|
-- |
|
$6.45M |
|
$4.09M |
|
$3.81M |
|
|
Increase/Decrease in Cash |
$-0.28M |
$4.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-190.02% |
|
-190.02% |
|
-109.06% |
|
-190.02% |
|
$0.16 |
|
$-0.49 |
|
$-0.49 |
|